Microwave-assisted synthesis of novel pyrazole, pyrimidine and pyrazolo[1,5-a]pyrimidines containing aryl sulfone moiety

Life Science Journal

Volumn 9, Issue 1, 2012, Pages 711-718

  El Kateb, Ahmed A ^a   El Rahman, Naglaa M Abd ^a,b   Saleh, Tamer S ^a,c   Zeid, Ibrahim F ^d   Mady, Mohamed F ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Aryl sulfone; Enaminone; Green chemistry; Microwave irradiation; Pyrazolo 1,5 a pyrimidine

Indexed keywords

EID: 84874893380     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. (a) Julino, M.; Stevens, F. G. M. Antitumour polycyclic acridines. Part 5.1 Synthesis of 7Hpyrido[4, 3, 2-kl]acridines with exploitable functionality in the pyridine ring. J. Chem. Soc. Perkin Trans. 1 1998, 1677-1684;
2. (b) Abdou, I. M.; Saleh, A. M.; Zohdi, H. F. Synthesis and antitumor activity of 5-trifluoromethyl-2, 4-dihydropyrazol-3-one nucleosides. Molecules 2004, 9, 109-116.
3. El-Feky, S. A.; Abd el-Samii, Z. K. Synthesis and antihypertensive activity of novel 1-(4-benzyl-1-phthalazinyl)-pyrazolo[3, 4-d]. pyrimidines. Pharmazie 1996, 51, 540-543.
4. (a) Davies, L. P.; Brown, D. J.; Chow, S. C.; Johnston, G. A. Pyrazolo[3, 4-d] pyrimidines, a new class of adenosine antagonists. Neurosci. Lett. 1983, 41, 189-193;
5. (b) Davies, L. P.; Chow, S. C.; Skerritt, J. H.; Brown, D. J.; Johnston, G. A., Pyrazolo[3, 4-d]pyrimidines as adenosine antagonists. Life Sci. 1984, 34, 2117-2128.
6. Ghorab, M. M.; Ismail, Z. H.; Abdel-Gawad, S. M.; Abdel Aziem, A. Antimicrobial activity of amino acid, imidazole, and sulfonamide derivatives of pyrazolo[3, 4-d]pyrimidine. Heteroatom Chem. 2004, 15, 57-62.
7. Holla, B. S.; Mahalinga, M.; Karthikeyan, M. S.; Akberali, P. M.; Shetty, N. S. Synthesis of some novel pyrazolo[3, 4-d]pyrimidine derivatives as potential antimicrobial agents. Bioorg. Med. Chem. 2006, 14, 2040-2047.
8. Gupta, S.; Rodrigues, L. M.; Esteves, A. P.; Oliveira-Campos, A. M.; Nascimento, M. S.; Nazareth, N.; Cidade, H.; Neves, M. P.; Fernandes, E.; Pinto, M.; Cerqueira, N. M.; Bras, N. Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors. Eur. J. Med. Chem. 2008, 43, 771-780.
9. Tamta, H.; Thilagavathi, R.; Chakraborti, A. K.; Mukhopahyay, A. K. 6-(N-benzoylamino)purine as a novel and potent inhibitor of xanthine oxidase: inhibition mechanism and molecular modeling studies. J. Enzyme Inhib. Med. Chem. 2005, 20, 317-324.
10. Bouabdallah, I.; M'Barek, L. A.; Zyad, A.; Ramdani, A.; Zidane, I.; Melhaoui, A. Anticancer effect of three pyrazole derivatives. Nat. Prod. Res. 2006, 20, 1024-1030.
11. Coimbra, C.; Boris-Moller, F.; Drake, M.; Wieloch, T. Diminished neuronal damage in the rat brain by late treatment with the antipyretic drug dipyrone or cooling following cerebral ischemia. Acta Neuropathol. 1996, 92, 447-453.
12. (a) Shaaban, M. R.; Saleh, T. S.; Mayhoub, A. S.; Mansour, A.; Farag, A. M. Synthesis and analgesic/anti-inflammatory evaluation of fused heterocyclic ring systems incorporating phenylsulfonyl moiety. Bioorg. Med. Chem. 2008, 16, 6344-6352;
13. (b) Shaaban, M. R.; Saleh, T. S.; Mayhoub, A. S.; Farag, A. M. Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors. Eur. J. Med. Chem. 2011, 46, 3690-3695.
14. Otzen, T.; Wempe, E. G.; Kunz, B.; Bartels, R.; Lehwark-Yvetot, G.; Hansel, W.; Schaper, K. J.; Seydel, J. K. Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicanssynthesis and biological activity of new 2, 4-diaminopyrimidines and 4'-substituted-4-aminodiphenyl sulfones. J. Med. Chem. 2004, 47, 240-253.
15. Sun, Z. Y.; Botros, E.; Su, A. D.; Kim, Y.; Wang, E.; Baturay, N. Z.; Kwon, C. H. Sulfoxide-containing aromatic nitrogen mustards as hypoxia-directed bioreductivecytotoxins. J. Med. Chem. 2000, 43, 4160-4168.
16. Neamati, N.; Mazumder, A.; Zhao, H.; Sunder, S.; Burke, T. R., Jr.; Schultz, R. J.; Pommier, Y. Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors. Antimicrob. Agents Chemother. 1997, 41, 385-93.
17. Doherty, G. A.; Kamenecka, T.; McCauley, E.; Van Riper, G.; Mumford, R. A.; Tong, S.; Hagmann, W. K. N-aryl 2, 6-dimethoxybiphenylalanine analogues as VLA-4 antagonists. Bioorg. Med. Chem. Lett. 2002, 12, 729-731.
18. Clemett, D.; Goa, K. L. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs 2000, 59, 957-980.
19. Bing, R. J.; Lomnicka, M. Why do cyclooxygenase-2 inhibitors cause cardiovascular events? J. Am. Coll. Cardiol. 2002, 39, 521-522.
20. Sikes, D. H.; Agrawal, N. M.; Zhao, W. W.; Kent, J. D.; Recker, D. P.; Verburg, K. M. Incidence of gastroduodenal ulcers associated with valdecoxib compared with that of ibuprofen and diclofenac in patients with osteoarthritis. Eur. J. Gastroenterol. Hepatol. 2002, 14, 1101-1111.
21. Langman, M. J.; Jensen, D. M.; Watson, D. J.; Harper, S. E.; Zhao, P. L.; Quan, H.; Bolognese, J. A.; Simon, T. J. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999, 282, 1929-1933.
22. Cochrane, D. J.; Jarvis, B.; Keating, G. M. Etoricoxib. Drugs 2002, 62, 2637-2651; discussion 2652-2653
23. Dallob, A.; Hawkey, C. J.; Greenberg, H.; Wight, N.; De Schepper, P.; Waldman, S.; Wong, P.; DeTora, L.; Gertz, B.; Agrawal, N.; Wagner, J.; Gottesdiener, K. Characterization of etoricoxib, a novel, selective COX-2 inhibitor. J. Clin. Pharmacol. 2003, 43, 573-585.
24. Todd, P. A.; Clissold, S. P. Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases. Drugs 1991, 41, 625-646.
25. Lee, C. R.; Balfour, J. A. Piroxicam-betacyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states. Drugs 1994, 48, 907-929.
26. Fleischmann, R.; Iqbal, I.; Slobodin, G. Meloxicam. Expert Opin. Pharmacother. 2002, 3, 1501-1512.
27. Zhao, H.; Ye, T. H.; Gong, Z. Y.; Xue, Y.; Xue, Z. G.; Huang, W. Q. Application of lornoxicam to patient-controlled analgesia in patients undergoing abdominal surgeries. Chin. Med. Sci. J. 2005, 20, 59-62.
28. Kurumaji, Y., Ampiroxicam-induced photosensitivity. Contact Dermatitis 1996, 34, 298-299.
29. Bernareggi, A. Clinical pharmacokinetics of nimesulide. Clin. Pharmacokinet. 1998, 35, 247-274.
30. Abd El-Rahman, N. M.; El-Kateb, A. A.; Mady, M. F. Simplified approach to the uncatalyzedknoevenagel condensation and michael addition reactions in water using microwave irradiation. Synth. Commun. 2007, 37, 3961-3970.
31. Campo, C. J.; Tato, V. P. M.; Seijas, A. J. Microwave-Promoted, One-Pot, Solvent-Free Synthesis of 4-Arylcoumarins from 2-Hydroxybenzophenones. Eur. J. Org. Chem. 2010, 4130-4135.
32. Abd El-Rahman, N. M.; Saleh, T. S.; Mady, M. F. Ultrasound assisted synthesis of some new 1, 3, 4-thiadiazole and bi(1, 3, 4-thiadiazole) derivatives incorporating pyrazolone moiety. Ultrason. Sonochem. 2009, 16, 70-74.
33. Saleh, T. S.; Abd El-Rahman, N. M. Ultrasound promoted synthesis of substituted pyrazoles and isoxazoles containing sulphone moiety. Ultrason. Sonochem. 2009, 16, 237-242.
34. Saleh, T. S.; Eldebss, T. M.; Albishri, H. M., Ultrasound assisted one-pot, three-components synthesis of pyrimido[1, 2-a]benzimidazoles and pyrazolo[3, 4-b]pyridines: A new access via phenylsulfonesynthon. Ultrason. Sonochem. 2012, 19, 49-55.
35. 1H long-range coupling constants in configuration assignment of some trisubstituted alkenes. Magn. Reson. Chem. 1994, 32, 567-568.
36. Al-Mousawi, S. M.; El-Apasery, M. A.; Elnagdi, M. H. Enaminones in heterocyclic synthesis: a novel route to tetrahydropyrimidines, dihydropyridines, triacylbenzenes and naphthofurans under microwave irradiation. Molecules 2010, 15, 58-67.
37. Stanovnik, B.; Svete, J. Synthesis of heterocycles from alkyl 3-(dimethylamino)propenoates and related enaminones. Chem. Rev. 2004, 104, 2433-2480.
38. Novinson, T.; Hanson, R.; Dimmitt, M. K.; Simon, L. N.; Robins, R. K.; O'Brien, D. E. 3-Substituted-5, 7-dimethylpyrazolo(1, 5-a) pyrimidines, 3', 5'-cyclic-AMP phosphodiesterase inhibitors. 1. J. Med. Chem. 1974, 17, 645-648.
39. Zou, J.; Li, F.; Tao, F. G. Microwave-assisted synthesis of diaryl or aryl-alkyl sulfones without catalyst. Chin. Chem. Lett. 2009, 20, 17-20.
40. Hori, I.; Igarashi, M. The Paal-Knorr Condensation of Acetonylacetone with 5-Aminopyrazoles. Bull. Chem. Soc. Jpn. 1971, 44, 2856-2858.
41. Elfahham, H. A.; Sadek, K. U.; Elgemeie, G. E. H.; Elnagdi, M. H. Novel synthesis of pyrazolo[5, 1-c]-1, 2, 4-triazoles, imidazo[1, 2-b]pyrazoles, and [1, 2, 4]-triazolo[4, 3-a]benzimidazoles. Reaction of nitrite imines with amino-and oxo-substituted diazoles. J. Chem. Soc. Perkin Trans. 1 1982, 2663-2666.